Our Pipeline
Pipeline
Selective Immunoproteasome Inhibition
Selective Immunoproteasome Inhibition
Title | DiscoveryDisc | Phase 1Ph1 | Phase 2Ph2 | Phase 3Ph3 |
---|---|---|---|---|
Zetomipzomib (KZR-616) | ||||
Lupus Nephritis (LN) | Zetomipzomib (KZR-616)Lupus Nephritis (LN) | |||
Autoimmune Hepatitis (AIH) | Autoimmune Hepatitis (AIH) | |||
Dermatomyositis (DM) Polymyositis (PM) | Dermatomyositis (DM) Polymyositis (PM) |
Protein Secretion Inhibition
Protein Secretion Inhibition
Title | DiscoveryDisc | Phase 1Ph1 | Phase 2Ph2 | Phase 3Ph3 |
---|---|---|---|---|
KZR-261 | ||||
Advanced/Metastatic Solid Tumor | KZR-261Advanced/Metastatic Solid Tumor | |||
Oral Anti-PD-1 | ||||
Single Target Oncology | Oral Anti-PD-1Single Target Oncology | |||
KZR-TBD | ||||
Multi Target Oncology | KZR-TBDMulti Target Oncology |